Vera Catharina Keil, Stilyana Peteva Bakoeva, Alina Jurcoane, Mariya Doneva, Thomas Amthor, Peter Koken, Burkhard Mädler, Guido Lüchters, Wolfgang Block, Ullrich Wüllner, Elke Hattingen
Parkinson's disease (PD) affects more than six million people, but reliable MRI biomarkers with which to diagnose patients have not been established. Magnetic resonance fingerprinting (MRF) is a recent quantitative technique that can provide relaxometric maps from a single sequence. The purpose of this study is to assess the potential of MRF to identify PD in patients and their disease severity, as well as to evaluate comfort during MRF. Twenty-five PD patients and 25 matching controls underwent 3 T MRI, including an axial 2D spoiled gradient echo MRF sequence...
August 11, 2020: NMR in Biomedicine